Who
Fahed Al-Marzooqi
Director
Company insider
Files Form 4 as: Director, vTv Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Jul 2022
- Last trade
- 26 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 29 Jun 2026 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $210K6,000 at $35.08 | filing |
| 26 Jun 2026filed 29 Jun 2026 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $210K6,000 at $35.08 | filing |
| 10 Jun 2025filed 12 Jun 2025 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $66K4,000 at $16.59 | filing |
| 25 Jun 2024filed 27 Jun 2024 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $52K3,000 at $17.22 | filing |
| 27 Feb 2024filed 13 Jun 2024 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $48K4,055 at $11.81 | filing |
| 19 Jun 2023filed 21 Jun 2023 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 13 Jul 2022filed 15 Jul 2022 | VTVT vTv Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.